Abstract
The role of acetaldehyde in reducing the oxidative pathway and increasing the reductive route for norepinephrine (NE) metabolism was evaluated. Experiments were performed in which 14C-NE was injected into rats and its metabolic fate in vivo was monitored in the urine. Ethanol administration failed to alter the biochemical disposition of this amine, whereas, acetaldehyde produced profound aberrations in NE metabolism. The excretion of 14C-vanillylmandelic acid and dihydroxymandelic acid was decreased as a result of treatment with acetaldehyde, disulfiram, or calcium carbimide. A concomitant increase in labeled 3-methoxy-4-hydroxyphenylglycol was also observed with these treatments. Administration of ethanol to animals previously treated with disulfiram or calcium carbimide potentiated this effect and resulted in elevated acetaldehyde blood levels as measured by a specific gas chromatographic procedure. These findings confirm the hypothesis that competitive inhibition of aldehyde dehydrogenase by acetaldehyde is the quantitatively important mechansim in the genesis of altered neuroamine metabolism by ethanol.
- Copyright ©, 1970, by Academic Press Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|